ALDEYRA THERAPEUTICS, INC. (ALDX) Net income 2016–2025
ALDEYRA THERAPEUTICS, INC. (ALDX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$33.8MFY2025 · since FY2016: -$18.7M → -$33.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.8M | +39.4% |
| FY2024 | -$55.9M | -48.8% |
| FY2023 | -$37.5M | +39.5% |
| FY2022 | -$62.0M | -7.4% |
| FY2021 | -$57.8M | -53.8% |
| FY2020 | -$37.6M | +38.3% |
| FY2019 | -$60.8M | -56.4% |
| FY2018 | -$38.9M | -74.1% |
| FY2017 | -$22.3M | -19.5% |
| FY2016 | -$18.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALDX financial trends
ALDX RevenueALDX Net marginALDX Gross profitALDX Gross marginALDX Operating incomeALDX Operating marginALDX Operating cash flowALDX Free cash flowALDX Capital expendituresALDX Return on equityALDX Stock buybacksALDX Dividends paidALDX Total assetsALDX Total liabilitiesALDX Shareholders’ equityALDX overview →